Europe Antimicrobial Susceptibility Testing Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
 예측 기간 |
2022 –2029 |
 시장 규모(기준 연도) |
USD 1,072.01 Million |
 시장 규모(예측 연도) |
USD 1,619.80 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
유럽 항균제 감수성 검사 시장, 제품 유형(기기, 소모품 및 액세서리, 서비스 및 소프트웨어), 방법(질량 분석법, 희석, 디스크 확산, E-테스트, 유전형 방법 및 기타), 유형(항균 검사, 항진균 검사 및 Rapid-AST), 응용 분야(임상 진단, 약물 발견 및 개발, 역학 및 기타), 최종 사용자(병원, 제약 및 생명 공학 회사, 진단 실험실, 계약 연구 기관, 연구 센터 및 학술 기관 및 기타), 유통 채널(직접 판매, 소매 판매 및 제3자 유통업체), 국가(독일, 영국, 프랑스, 이탈리아, 스페인, 러시아, 네덜란드, 스위스, 벨기에, 터키 및 기타 유럽 국가) 산업 동향 및 2029년까지의 예측.
시장 분석 및 통찰력 : 유럽 항균제 감수성 테스트 시장
항균제 감수성 검사 시장은 2022년에서 2029년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년에서 2029년의 예측 기간 동안 5.4%의 CAGR로 성장하고 있으며 2021년의 1,072.01백만 달러에서 2029년까지 1,619.80백만 달러에 도달할 것으로 예상된다고 분석했습니다. 감염성 질환의 높은 유병률과 조기 진단에 대한 인식 증가는 예측 기간 동안 시장을 추진하는 주요 원동력입니다.
항균제 감수성 검사(AST)는 특정 감염을 일으키는 박테리아, 진균 및 기타 미생물의 성장을 방해하는 항균제를 판별하는 데 사용되는 실험실 절차입니다. 감수성 검사는 표본 배양에서 회수된 후 감염을 일으키는 박테리아, 진균과 같은 미생물에 대해 수행됩니다.
항균제는 감염성 질환 예방에 중요한 역할을 하지만, 약물 남용 및 과용의 경우 약물 내성이 발달하게 되었습니다. 유해한 미생물을 진단하는 데 지연이 발생하면 감염성 질환의 확산을 통제하기 어렵습니다. 이는 핵심 참여자에게 환자를 더 잘 치료할 수 있는 정확하고 효과적인 결과를 제공하는 검사 키트를 제조하라는 압력을 가하고 있습니다.
검사는 미생물에 대한 항생제의 잠재적 효과를 결정하고 미생물이 특정 항생제에 대한 내성을 개발했는지 확인하는 데 사용됩니다. 이 검사 결과는 의료 전문가가 더 나은 임상 진단을 받고 특정 감염을 치료하는 데 가장 효과적일 가능성이 높은 약물을 선택하는 데 도움이 될 수 있습니다.
유럽 항균제 감수성 검사 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 창출, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 기회 분석을 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.
유럽 항균제 감수성 테스트 시장 범위 및 시장 규모
유럽 항균제 감수성 검사 시장은 제품 유형, 방법, 유형, 응용 분야, 최종 사용자 및 유통 채널을 기준으로 6가지 주요 부문으로 분류됩니다.
- 제품 유형을 기준으로 항균제 감수성 검사 시장은 기기, 소모품 및 액세서리, 서비스 및 소프트웨어로 세분화됩니다. 2022년에는 다양한 유형의 AST 기기가 시장에 출시됨에 따라 기기 부문이 시장을 지배할 것으로 예상됩니다.
- 방법에 따라 항균제 감수성 검사 시장은 질량 분석법, 희석법, 디스크 확산법, e-테스트, 유전형법, 신속 AST로 세분화됩니다. 2022년에는 디스크 확산법이 항균제 감수성 검사에 널리 사용되는 방법이기 때문에 시장을 지배할 것으로 예상됩니다.
- 유형에 따라 항균제 감수성 검사 시장은 항균 검사, 항진균 검사 및 기타로 세분화됩니다. 2022년에는 다중 약물 내성 유기체의 높은 유병률로 인해 항균 검사 부문이 시장을 지배할 것으로 예상됩니다.
- 응용 프로그램을 기준으로 항균제 감수성 검사 시장은 임상 진단, 약물 발견 및 개발, 역학 및 기타로 세분화됩니다. 2022년에는 임상 진단 부문이 시장을 지배할 것으로 예상되는데, 이러한 검사는 미생물학자가 더 나은 임상 진단에 접근할 수 있도록 미생물을 감지하는 데 가장 자주 수행되기 때문입니다.
- 최종 사용자를 기준으로 항균제 감수성 검사 시장은 병원, 제약 및 생명공학 회사, 진단 실험실, 계약 연구 기관, 연구 센터 및 학술 기관 등으로 세분화됩니다. 2022년에는 병원 부문이 시장을 지배할 것으로 예상되는데, 이러한 항균제 검사는 적절한 치료를 위한 최신 기계와 시설을 갖추고 있어 병원에서 대부분 수행되기 때문입니다.
- 유통 채널을 기준으로 항균 감수성 검사 시장은 직접 판매, 소매 판매 및 제3자 유통업체로 세분화됩니다. 2022년에는 직접 판매 부문이 시장을 지배할 것으로 예상되는데, 직접 판매가 기기를 구매하는 가장 선호되는 채널이기 때문입니다.
항균제 감수성 테스트 시장 국가 수준 분석
유럽 항균제 감수성 검사 시장은 제품 유형, 방법, 유형, 응용 분야, 최종 사용자 및 유통 채널을 기준으로 6가지 주요 부문으로 분류됩니다.
The countries covered in the antimicrobial susceptibility testing market report are the Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and rest of Europe.
Europe is expected to grow with the third highest growth rate in the forecast period of 2022 to 2029 due to increasing initiatives taken by key market players in the region. Germany is dominating the European market due to the rise in epidemic and pandemic events.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Collaboration by the Players for Development of New Advanced Antimicrobial Susceptibility Testing is Creating New Opportunities for Players in the Antimicrobial Susceptibility Testing Market
Antimicrobial susceptibility testing market also provides you with detailed market analysis for every country growth in particular industry with wearable electronic devices sales, impact of advancement in the antimicrobial susceptibility testing and changes in regulatory scenarios with their support for the wearable electronic devices market. The data is available for historic period 2012 to 2020.
Competitive Landscape and Antimicrobial Susceptibility Testing Market Share Analysis
Antimicrobial susceptibility testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to antimicrobial susceptibility testing market.
항균제 감수성 검사 시장에서 거래하는 주요 기업으로는 BD, Synbiosis, Zhuhai DL Biotech Co., Ltd, Mast Group Ltd., HiMedia Laboratories, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Creative Diagnostics, Genefluidics, Inc., Rosco Diagnostica A/S, ERBA Group, Liofilchem Srl, Alifax Srl, MERLIN Gesellschaft für mikrobiologische Diagnostika mbH, bioMérieux SA, Merck KGaA, Danaher, Accelerate Diagnostics, Inc., NuMedii, Inc., BacterioScan, Inc. 등이 있습니다. 국내 및 아시아 태평양 지역의 다른 기업도 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.
또한 전 세계 여러 회사에서 제품 출시와 계약을 체결하여 시장을 가속화하고 있습니다.
예를 들어,
- 2020년 4월 Thermo Fisher Scientific Inc.는 자동화 및 수동 항균제 감수성 검사 포트폴리오에 imipenem/relebactam ARIS HiQ를 추가했으며, 이는 요로 감염 치료제로 사용될 것입니다. 또한 임상 환경에서 항균제 검사 옵션도 확대될 것입니다. 이는 향후 몇 년 동안 시장 성장을 촉진할 것입니다.
시장 참여자의 협력, 합작투자 및 기타 전략은 웨어러블 전자 기기 시장에서 회사 시장을 확대하고 있으며, 이를 통해 기업은 항균제 감수성 검사에 대한 제공 서비스를 개선할 수 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN EPIDEMIC AND PANDEMIC OUTBREAK
5.1.2 INCREASING PREVALENCE OF MULTI-DRUG RESISTANCE ORGANISM
5.1.3 AVAILABILITY OF ADVANCED ANTIMICROBIAL SUSCEPTIBILITY TESTING METHODS
5.1.4 HIGH PREVALENCE OF INFECTIOUS DISEASES
5.1.5 DEVELOPMENT OF NEW GENOMIC IDENTIFICATION METHODS
5.2 RESTRAINTS
5.2.1 STRINGENT GOVERNMENT REGULATIONS
5.2.2 HIGH COSTS OF AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING SYSTEMS
5.2.3 SHORTAGE OF SKILLED PERSONNEL
5.3 OPPORTUNITIES
5.3.1 INCREASING PRODUCT LAUNCHES
5.3.2 INCREASE IN FUNDING
5.3.3 STRATEGIC DECISIONS TAKEN BY KEY MARKET PLAYERS
5.4 CHALLENGES
5.4.1 EMERGENCE OF LOCAL PLAYERS
5.4.2 DELAYS BETWEEN CLINICAL BREAKPOINT AND ITS CLEARANCE
5.4.3 LACK OF CLINICAL DATA FROM FDA
6 IMPACT OF COVID-19 ON EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY
6.4 KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19
6.5 CONCLUSION:
7 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 INSTRUMENTS
7.2.1 MANUAL
7.2.1.1 MINIATURIZED IDENTIFICATION SYSTEMS
7.2.1.2 SUSCEPTIBILITY TESTING DISCS
7.2.1.2.1 DODECA DISCS
7.2.1.2.1.1 GENERAL PURPOSE
7.2.1.2.1.2 GRAM NEGATIVE ORGANISM
7.2.1.2.1.3 GRAM POSITIVE ORGANISM
7.2.1.2.1.4 PSEUDOMONAS
7.2.1.2.1.5 UTI ORGANISMS
7.2.1.2.2 HEXA DISCS
7.2.1.2.2.1 GRAM NEGATIVE ORGANISMS
7.2.1.2.2.2 GRAM POSITIVE ORGANISMS
7.2.1.2.2.3 GENERAL PURPOSE
7.2.1.2.2.4 ANAEROBIC BACTERIA
7.2.1.2.2.5 ANTIFUNGAL
7.2.1.2.2.6 OTHERS
7.2.1.2.3 ICOSA DISCS
7.2.1.2.3.1 GENERAL PURPOSE
7.2.1.2.3.2 PSEUDOMONAS
7.2.1.2.3.3 UTI ORGANISMS
7.2.1.2.4 OCTO DISCS
7.2.1.2.4.1 GRAM NEGATIVE ORGANISMS
7.2.1.2.4.2 GRAM POSITIVE ORGANISMS
7.2.1.2.4.3 UTI ORGANISMS
7.2.1.2.4.4 PSEUDOMONAS
7.2.1.2.4.5 GENERAL PURPOSE
7.2.1.2.4.6 OTHERS
7.2.1.2.5 MIC STRIPS
7.2.1.2.5.1 COMBINATION ANTIBACTERIAL
7.2.1.2.5.2 DUAL ANTIBACTERIAL
7.2.1.2.5.3 MULTIPLE ANTIBACTERIAL
7.2.1.2.5.4 SINGLE ANTIBACTERIAL
7.2.1.2.5.5 ANTIFUNGAL
7.2.1.2.5.6 OTHERS
7.3 AUTOMATED IDENTIFICATION AND SUSCEPTIBILITY TESTING SYSTEM
7.4 CONSUMABLES & ACCESSORIES
7.4.1 REAGENTS & BROTHS
7.4.2 MEDIA
7.4.3 SUSCEPTIBILITY PANELS
7.4.4 OTHERS
7.5 SERVICES & SOFTWARE
8 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS
8.1 OVERVIEW
8.2 DISK DIFFUSION
8.3 DILUTION
8.4 MASS SPECTROMETRY METHOD
8.5 E-TEST
8.6 GENEOTYPIC METHODS
8.7 RAPID-AST
9 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE
9.1 OVERVIEW
9.2 ANTI BACTERIAL TESTING
9.3 ANTI FUNGAL TESTING
9.4 OTHERS
10 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 CLINICAL DIAGNOSTICS
10.3 DRUG DISCOVERY AND DEVELOPMENT
10.4 EPIDEMIOLOGY
10.5 OTHERS
11 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 DIAGNOSTIC LABORATORIES
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.5 CONTRACT RESEARCH ORGANIZATIONS
11.6 RESEARCH CENTRES AND ACADEMIC INSTITUTES
11.7 OTHERS
12 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT SALES
12.3 RETAIL SALES
12.4 THIRD PARTY DISTRIBUTOR
13 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 U.K.
13.1.3 FRANCE
13.1.4 ITALY
13.1.5 SPAIN
13.1.6 RUSSIA
13.1.7 NETHERLANDS
13.1.8 SWITZERLAND
13.1.9 BELGIUM
13.1.10 TURKEY
13.1.11 REST OF EUROPE
14 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 THERMO FISHER SCIENTIFIC INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 BIOMÉRIEUX SA
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 MERCK KGAA
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 DANAHER
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 ACCELERATE DIAGNOSTICS, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENTS
16.6 ALIFAX S.R.L.
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 BACTERIOSCAN, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 BD
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENTS
16.9 BIO-RAD LABORATORIES, INC.
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 COMPANY SHARE ANALYSIS
16.9.4 PRODUCT PORTFOLIO
16.9.5 RECENT DEVELOPMENTS
16.1 CREATIVE DIAGNOSTICS
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 ERBA GROUP
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 GENEFLUIDICS, INC.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 HIMEDIA LABORATORIES
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENTS
16.14 LIOFILCHEM S.R.L.
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT PORTFOLIO
16.14.3 RECENT DEVELOPMENTS
16.15 MAST GROUP LTD.
16.15.1 COMPANY SNAPSHOT
16.15.2 PRODUCT PORTFOLIO
16.15.3 RECENT DEVELOPMENTS
16.16 MERLIN GESELLSCHAFT FUR MICROBIOLOGISCHE DIAGNOSTIKA MBH
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENTS
16.17 NUMEDII, INC.
16.17.1 COMPANY SNAPSHOT
16.17.2 TECHNOLOGY PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 ROSCO DIAGNOSTICA A/S
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 SYNBIOSIS
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 ZHUHAI DL BIOTECH CO., LTD
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 EUROPE INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 EUROPE INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 4 EUROPE MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 EUROPE SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 EUROPE DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 7 EUROPE HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 8 EUROPE ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 EUROPE OCT0 DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 10 EUROPE MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 11 EUROPE CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 EUROPE CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 EUROPE SERVICES & SOFTWARE IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 15 EUROPE DISK DIFFUSION IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 EUROPE DILUTION IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 EUROPE MASS SPECTROMETRY METHOD IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 EUROPE E-TEST IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 EUROPE GENEOTYPIC METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 EUROPE RAPID-AST IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 22 EUROPE ANTI BACTERIAL TESTING IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 EUROPE ANTI FUNGAL TESTING IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 EUROPE OTHERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 EUROPE CLINICAL DIAGNOSTICS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 EUROPE DRUG DISCOVERY AND DEVELOPMENT IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 EUROPE EPIDEMIOLOGY IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 EUROPE OTHERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 31 EUROPE HOSPITALS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 EUROPE DIAGNOSTIC LABORATORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 EUROPE RESEARCH CENTRES AND ACADEMIC INSTITUTES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 EUROPE OTHERS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 38 EUROPE DIRECT SALES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 EUROPE RETAILS SALES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 40 EUROPE THIRD PARTY DISTRIBUTOR IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 42 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 43 EUROPE INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 44 EUROPE MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 45 EUROPE SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 46 EUROPE DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 47 EUROPE HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 48 EUROPE ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 49 EUROPE OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 50 EUROPE MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 51 EUROPE CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 52 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 53 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 55 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 56 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 58 GERMANY INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 59 GERMANY MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 60 GERMANY SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 61 GERMANY DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 62 GERMANY HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 63 GERMANY ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 64 GERMANY OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 65 GERMANY MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 66 GERMANY CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 67 GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 68 GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 70 GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 71 GERMANY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 72 U.K. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 73 U.K. INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 74 U.K. MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 75 U.K. SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 76 U.K. DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 77 U.K. HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 78 U.K. ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 79 U.K. OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 80 U.K. MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 81 U.K. CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 82 U.K. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 83 U.K. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 84 U.K. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 85 U.K. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 86 U.K. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 87 FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 88 FRANCE INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 89 FRANCE MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 90 FRANCE SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 91 FRANCE DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 92 FRANCE HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 93 FRANCE ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 94 FRANCE OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 95 FRANCE MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 96 FRANCE CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 97 FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 98 FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 99 FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 100 FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 101 FRANCE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 102 ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 103 ITALY INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 104 ITALY MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 105 ITALY SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 106 ITALY DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 107 ITALY HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 108 ITALY ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 109 ITALY OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 110 ITALY MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 111 ITALY CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 112 ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 113 ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 114 ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 115 ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 116 ITALY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 117 SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 118 SPAIN INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 119 SPAIN MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 120 SPAIN SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 121 SPAIN DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 122 SPAIN HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 123 SPAIN ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 124 SPAIN OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 125 SPAIN MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 126 SPAIN CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 127 SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 128 SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 129 SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 130 SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 131 SPAIN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 132 RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 133 RUSSIA INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 134 RUSSIA MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 135 RUSSIA SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 136 RUSSIA DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 137 RUSSIA HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 138 RUSSIA ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 139 RUSSIA OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 140 RUSSIA MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 141 RUSSIA CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 142 RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 143 RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 144 RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 145 RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 146 RUSSIA ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 147 NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 148 NETHERLANDS INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 149 NETHERLANDS MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 150 NETHERLANDS SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 151 NETHERLANDS DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 152 NETHERLANDS HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 153 NETHERLANDS ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 154 NETHERLANDS OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 155 NETHERLANDS MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 156 NETHERLANDS CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 157 NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 158 NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 159 NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 160 NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 161 NETHERLANDS ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 162 SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 163 SWITZERLAND INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 164 SWITZERLAND MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 165 SWITZERLAND SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 166 SWITZERLAND DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 167 SWITZERLAND HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 168 SWITZERLAND ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 169 SWITZERLAND OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 170 SWITZERLAND MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 171 SWITZERLAND CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 172 SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 173 SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 174 SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 175 SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 176 SWITZERLAND ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 177 BELGIUM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 178 BELGIUM INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 179 BELGIUM MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 180 BELGIUM SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 181 BELGIUM DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 182 BELGIUM HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 183 BELGIUM ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 184 BELGIUM OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 185 BELGIUM MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 186 BELGIUM CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 187 BELGIUM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 188 BELGIUM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 189 BELGIUM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 190 BELGIUM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 191 BELGIUM ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 192 TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 193 TURKEY INSTRUMENTS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 194 TURKEY MANUAL IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 195 TURKEY SUSCEPTIBILITY TESTING DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 196 TURKEY DODECA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 197 TURKEY HEXA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 198 TURKEY ICOSA DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 199 TURKEY OCTO DISCS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 200 TURKEY MIC STRIPS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 201 TURKEY CONSUMABLES & ACCESSORIES IN ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 202 TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHODS, 2020-2029 (USD MILLION)
TABLE 203 TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 204 TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 205 TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 206 TURKEY ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 207 REST OF EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
그림 목록
FIGURE 1 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SEGMENTATION
FIGURE 2 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DROC ANALYSIS
FIGURE 4 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE ANTIMICROBIAL SUSCEPTIILITY TESTING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SEGMENTATION
FIGURE 11 RISE IN EPIDEMIC AND PANDEMIC OUTBREAK AND INCREASING PREVALENCE OF MULTI-DRUG RESISTANT ORGANISM IS EXPECTED TO DRIVE THE EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN 2022 & 2029
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
FIGURE 15 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE, 2021
FIGURE 16 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE, 2020-2029 (USD MILLION)
FIGURE 17 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 18 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY METHODS, 2021
FIGURE 20 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY METHODS, 2020-2029 (USD MILLION)
FIGURE 21 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY METHODS, CAGR (2022-2029)
FIGURE 22 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY METHODS, LIFELINE CURVE
FIGURE 23 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY TYPE, 2021
FIGURE 24 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY TYPE, 2020-2029 (USD MILLION)
FIGURE 25 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 26 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY TYPE, LIFELINE CURVE
FIGURE 27 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY APPLICATION, 2021
FIGURE 28 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY APPLICATION, 2020-2029 (USD MILLION)
FIGURE 29 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 30 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY END USER, 2021
FIGURE 32 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 33 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY END USER, CAGR (2022-2029)
FIGURE 34 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 36 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 37 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 38 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 39 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: SNAPSHOT (2021)
FIGURE 40 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY COUNTRY (2021)
FIGURE 41 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY COUNTRY (2022 & 2029)
FIGURE 42 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY COUNTRY (2021 & 2029)
FIGURE 43 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 44 EUROPE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: COMPANY SHARE 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
